• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • 2026 Election
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • Trump Administration
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • 2026 Election
  • Trump Administration
  • IN FOCUS
  • Commentary
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
  • Newsletters
More
    Home Tags Pharmaceutical Industry

    Tag: Pharmaceutical Industry

    oto, Seema Verma, President Trump's nominee to head the Centers for Medicare and Medicaid Services, refused to endorse giving Medicare the power to negotiate drug prices. (AP Photo/Evan Vucci File)
    Healthcare

    CMS pick won’t commit to Medicare drug price negotiations

    Robert King -
    February 16, 2017 4:59 pm
    0
    Rep. Elijah Cummings, shown, and Sen. Bernie Sanders, I-Vt., expressed outrage that Marathon Pharmaceuticals planned to charge $89,000 a year for a drug that's widely available abroad for about $1,000 a year. (AP Photo/Manuel Balce Ceneta, File)
    Healthcare

    Another day, another drugmaker getting yelled at

    Robert King -
    February 14, 2017 5:01 am
    0
    CEO says drugmaker will meet with advocates to explain company's plans and review the community's concerns. (AP Photo/Sue Ogrocki, File)
    Healthcare

    $89,000 drug delays launch

    Robert King -
    February 13, 2017 11:01 pm
    0
    The Food and Drug Administration gave the nod to 22 new medications, after approving 45 in 2015. (AP Photo/Julio Cortez, File)
    Healthcare

    $89,000 price of new drug gets lawmakers riled up

    Robert King -
    February 13, 2017 7:06 pm
    0
    Democrats ask drug maker why it raised the price of an auto-injector of naloxone from $690 in 2014 to $4,500. (AP Photo/Ted S. Warren)
    Healthcare

    Senators fume over price hike of overdose antidote

    Robert King -
    February 8, 2017 6:47 pm
    0
    Bernie Sanders and Ted Cruz is a quintessential odd couple on healthcare, but the two senators did agree on one issue: drug re-importation. (AP Photo/Rich Pedroncelli, File)
    Healthcare

    Cruz, Sanders find common ground on drug prices

    Robert King -
    February 8, 2017 3:57 am
    0
    Gilead Sciences was widely criticized by Congress for the high prices of Sovaldi and Harvoni. (AP Photo/Eric Risberg, File)
    Healthcare

    Sales plunge for maker of hepatitis C cures

    Robert King -
    February 7, 2017 11:10 pm
    0
    The new version of the EpiPen will cost half as much, as the company responds to public outrage. (AP Photo/Pablo Martinez Monsivais, File)
    Healthcare

    Lawmakers say Mylan stonewalling them

    Robert King -
    February 3, 2017 10:38 pm
    0
    American Made Coalition has been created to advocate for the border adjustment provision of the plan. (AP Photo/Elaine Thompson)
    Economy

    House GOP tax plan gets boost from GE, Boeing, others

    Joseph Lawler -
    February 2, 2017 6:26 pm
    0
    Merck CEO Kenneth Frazier listens as President Trump speaks during a meeting with pharmaceutical industry leaders.
    Healthcare

    Trump meets with pharmaceutical execs, vows to cut drug prices

    Sarah Bedford -
    January 31, 2017 3:23 pm
    0
    1...111112113...156Page 112 of 156
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter
    • © Copyright 2026. Washington Examiner. All Rights Reserved.